Adaptive Biotechnologies Stock Quote ADPT - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

4.47

Bid

4.10

Ask

4.84

Volume

672,737

4.26 Day's Range 4.71

2.28 52 Week Range 6.34

Market Cap

659.201M

Previous Close

4.65

Open

4.71

Last Trade

4.26

Last Trade Time

Financial Volume

$ 2,959,309

VWAP

4.3989

Average Volume (3m)

1,185,136

Shares Outstanding

147,472,201

Dividend Yield

PE Ratio

-2.79

Earnings Per Share (EPS)

-1.53

Revenue

170.28M

Net Profit

-225.25M

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for... Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.adaptivebiotech.com

Headquarters

Olympia, Washington, USA

Founded

Adaptive Biotechnologies Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ADPT. The last closing price for Adaptive Biotechnologies was $4.65. Over the last year, Adaptive Biotechnologies shares have traded in a share price range of $ 2.28 to $ 6.34.

Adaptive Biotechnologies currently has 147,472,201 shares outstanding. The market capitalization of Adaptive Biotechnologies is $685.75 million. Adaptive Biotechnologies has a price to earnings ratio (PE ratio) of -2.79.

Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

SEATTLE, May 31, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.11	-2.40174672489	4.58	4.98	4.1813	848094	4.65182033	CS
4	-0.48	-9.69696969697	4.95	4.98	4.085	784659	4.51525516	CS
12	0.77	20.8108108108	3.7	5.04	3.3	1185136	4.3386443	CS
26	1.23	37.962962963	3.24	5.04	2.28	1482982	3.57853061	CS
52	-0.52	-10.4208416834	4.99	6.34	2.28	1496346	3.95452209	CS
156	-34.79	-88.6143657667	39.26	39.62	2.28	1249370	8.21942764	CS
260	-35.48	-88.8110137672	39.95	71.25	2.28	1110297	18.49446969	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
KAVLKaival Brands Innovations Group Inc	$ 1.33 (129.71%)	182.46M
LASELaser Photonics Corporation	$ 18.8671 (81.24%)	13.54M
TGLTreasure Global Inc	$ 1.18 (73.45%)	139.95M
NVVENuvve Holding Corporation	$ 6.68 (70.41%)	31.34M
UXINUxin Ltd	$ 2.42 (52.68%)	18.24M
ELABElevai Labs Inc	$ 0.10545 (-62.34%)	23.66M
ADTXAditxt Inc	$ 0.262 (-31.52%)	3.17M
FRGTFreight Technologies Inc	$ 0.081 (-28.82%)	26.35M
ANEBAnebulo Pharmaceuticals Inc	$ 2.23 (-27.60%)	113.78k
STSSSharps Technology Inc	$ 0.1722 (-27.06%)	2.27M
XPONExpion360 Inc	$ 0.1144 (34.91%)	432.14M
NVDANVIDIA Corporation	$ 116.26 (0.22%)	206.23M
INTCIntel Corporation	$ 22.56 (3.30%)	184.43M
KAVLKaival Brands Innovations Group Inc	$ 1.33 (129.71%)	182.45M
TGLTreasure Global Inc	$ 1.18 (73.45%)	139.93M